[HTML][HTML] Renal ischemia/reperfusion injury; from pathophysiology to treatment

M Malek, M Nematbakhsh - Journal of renal injury prevention, 2015 - ncbi.nlm.nih.gov
Ischemia/reperfusion injury (IRI) is caused by a sudden temporary impairment of the blood
flow to the particular organ. IRI usually is associated with a robust inflammatory and …

Acute kidney injury overview: from basic findings to new prevention and therapy strategies

SR Gonsalez, AL Cortês, RC da Silva, J Lowe… - Pharmacology & …, 2019 - Elsevier
Acute kidney injury (AKI) is defined as a decrease in kidney function within hours, which
encompasses both injury and impairment of renal function. AKI is not considered a …

Matrix metalloproteinases in kidney homeostasis and diseases

RJ Tan, Y Liu - American journal of physiology-renal …, 2012 - journals.physiology.org
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that have
been increasingly linked to both normal physiology and abnormal pathology in the kidney …

Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia

AL Solevåg, GM Schmölzer, PY Cheung - Free Radical Biology and …, 2019 - Elsevier
Perinatal asphyxia-induced brain injury may present as hypoxic-ischemic encephalopathy in
the neonatal period, and disability including cerebral palsy in the long term. The brain injury …

Renoprotective approaches and strategies in acute kidney injury

Y Yang, M Song, Y Liu, H Liu, L Sun, Y Peng… - Pharmacology & …, 2016 - Elsevier
Acute kidney injury (AKI) is a major renal disease associated with high mortality rate and
increasing prevalence. Decades of research have suggested numerous chemical and …

[HTML][HTML] Antioxidant effect of p-coumaric acid on interleukin 1-β and tumor necrosis factor-α in rats with renal ischemic reperfusion

SM Godarzi, AV Gorji, B Gholizadeh, SA Mard… - Nefrologia, 2020 - Elsevier
Background and aims Renal ischemia-reperfusion occurs in some clinical conditions such
as kidney surgery that can leads to acute renal failure. The aim of this study was to …

Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury

X Deng, T Zeng, J Li, C Huang, M Yu, X Wang… - Biomaterials …, 2019 - pubs.rsc.org
Bad water solubility and undesired toxicity of triptolide (TP) still restrict its clinical
applications in renal diseases. In this work, well-defined, monodispersed, and uniform-sized …

Matrix metalloproteinases as drug targets in ischemia/reperfusion injury

E Dejonckheere, RE Vandenbroucke, C Libert - Drug discovery today, 2011 - Elsevier
Deficient blood supply (ischemia) is a common consequence of some surgical procedures
and certain pathologies. Once blood circulation is re-established (reperfusion), a complex …

Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease

O Zakiyanov, M Kalousová, T Zima, V Tesař - Advances in Clinical …, 2021 - Elsevier
Matrix metalloproteinases (MMPs) are a group of zinc and calcium endopeptidases which
cleave extracellular matrix (ECM) proteins. They are also involved in the degradation of cell …

Matrix metalloproteinases in kidney disease: role in pathogenesis and potential as a therapeutic target

AR Parrish - Progress in molecular biology and translational …, 2017 - Elsevier
Matrix metalloproteinases (MMPs) are large family of proteinases. In addition to a
fundamental role in the remodeling of the extracellular matrix, they also cleave a number of …